A8424612
Wiskostatin , 98%(HPLC) , 253449-04-6
Synonym(s):
1-(3,6-dibromocarbazol-9-yl)-3-(dimethylamino)propan-2-ol;Wiskostatin - CAS 253449-04-6 - Calbiochem
CAS NO.:253449-04-6
Empirical Formula: C17H18Br2N2O
Molecular Weight: 426.15
MDL number: MFCD00218393
| Pack Size | Price | Stock | Quantity |
| 5MG | RMB959.20 | In Stock |
|
| 25MG | RMB3839.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 153-155 |
| Boiling point: | 320.2±22.0 °C(Predicted) |
| Density | 1.62±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO: soluble10mg/mL, clear |
| pka | 14.40±0.20(Predicted) |
| form | White solid |
| color | white to beige |
| Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
Description and Uses
Wiskostatin (253449-04-6) is a selective, reversible inhibitor of neural Wiskott-Aldrich syndrome protein (N-WASP) activity1. Binds to the regulatory domain of N-WASP and inhibits activation of Arp2/3 complex by forcing N-WASP into an inactive conformation2. Inhibits PIP2-induced actin polymerization (EC50=4 μM). Wiskostatin perturbs agrin-elicited acetylcholine receptor clustering3. Inhibits the formation of dendritic spines and synapses in hippocampal neurons.
Wiskostatin has been used:
- as a small-molecule inhibitor of Wiskott-Aldrich syndrome protein (WASP) in human osteosarcoma U2OS cells and mouse-tail fibroblast cell lines
- as a neural (N)-WASP inhibitor in cultured neurons and in the human embryonic kidney (HEK293) cells expressing HA-Parkin
- as a neural (N)-WASP inhibitor in dorsal root ganglion (DRG) cells to investigate vascular endothelial growth factor (VEGF) effect on the actin related protein 2/3 complex (Arp 2/3)




![1-(3,6-DIBROMO-CARBAZOL-9-YL)-3-[4-(4-FLUORO-PHENYL)-PIPERAZIN-1-YL]-PROPAN-2-OL](https://img.chemicalbook.com/CAS/GIF/607393-54-4.gif)